Extract
The European Sleep Apnoea Database (ESADA) study began in 2007 as a joint project within the European Union (EU) Cooperation in Science and Technology (COST) Action B26 on obstructive sleep apnoea (OSA) and cardiovascular risk, as a network of nationally appointed sleep apnoea experts. At that time, there were few cohorts of OSA patients, mainly in the context of epidemiological studies in the general population [1–6]. The COST Action only provided funding for networking, and each participating centre entered data into the web-based database on a voluntary basis. Collected data included anthropometrics, results of blood tests, current medications, and sleep data derived from full polysomnography or cardiorespiratory nocturnal monitoring, according to the diagnostic procedure chosen by the physician. Importantly, quality controls of the dataset were performed at regular intervals since the start of the project.
Abstract
The European Sleep Apnoea Database (ESADA) ERS Clinical Research Collaboration records data in over 25 000 patients with OSA from 33 European countries, to conduct clinical research and improve OSA patient care and outcomes http://ow.ly/DuDf30lZRP6
Footnotes
Collaborators: M.R. Bonsignore and J. Hedner are Chairs of the ESADA Clinical Research Collaboration. Collaborators in the ESADA project (current and past) by country and sleep centre were as follows. Belgium: J. Verbraecken and E. Petiet (Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital and University of Antwerp, Antwerp); D. Rodenstein (Cliniques Universitaires Saint-Luc, Brussels). Croatia: Z. Dogas and T. Galic (Sleep Medicine Center, Dept of Neuroscience, University of Split School of Medicine, Split). Czech Republic: O. Ludka (Dept of Cardiology, University Hospital Brno and International Clinical Research Center, St Ann's University Hospital, Brno); M. Pretl (Centre for Sleep and Waking Disorders, Dept of Neurology, First Faculty of Medicine, Charles University, Prague, and Inspamed, Neurology and Sleep Laboratory, Prague). Finland: U. Anttalainen and T. Saaresranta (Division of Medicine, Dept of Pulmonary Diseases, Turku University Hospital and Sleep Research Centre, Dept of Pulmonary Diseases and Clinical Allergology, University of Turku). France: P. Levy and J-L. Pépin (Université Grenoble Alpes, INSERM HP2 (U1042) and Grenoble University Hospital, Grenoble); P. Escourrou and G. Roisman (Service d’Éxplorations Fonctionnelles Multidisciplinaires and Unité de Médecine du Sommeil, Hospital Antoine Beclere, Clamart). Germany: I. Fietze and T. Penzel (Schlafmedizinisches Zentrum, Charité – Universitätsmedizin Berlin); R. Schulz (Sleep Disorders Centre, University of Giessen, Lung Centre, Giessen); H. Hein (Sleep Disorders Center, St Adolf Stift, Reinbeck). Greece: P. Steiropoulos (Sleep Unit, Dept of Pneumonology, Democritus University of Thrace, Alexandroupolis); G. Trakada (Pulmonary Medicine, National and Kapodistrian University of Athens, Athens); I. Bouloukaki and S. Schiza (Sleep Disorders Unit, Dept of Respiratory Medicine, Medical School, University of Crete); A. Pataka (Respiratory Failure Unit, G. Papanikolaou Hospital, Thessalonika). Ireland: W.T. McNicholas (Dept of Respiratory Medicine, St Vincent's University Hospital, Dublin); S. Ryan (Pulmonary and Sleep Disorders Unit, St Vincent's University Hospital, Dublin). Israel: L. Lavie and P. Lavie (Centre for Sleep Medicine, Technion Institute of Technology, Haifa). Italy: C. Lombardi and G. Parati (Istituto Auxologico Italiano, Ospedale San Luca, Milan); M.R. Bonsignore (Biomedical Department of Internal Medicine and Medical Specialties (DiBiMIS), Section of Pneumology, University of Palermo, and CNR Institute of Biomedicine and Molecular Immunology, Palermo); O. Marrone (CNR Institute of Biomedicine and Molecular Immunology, Palermo). Latvia: A. Vitols (Institute of Cardiology, University of Latvia, Riga). Lithuania: G. Varoneckas (Institute Psychophysiology and Rehabilitation, Palanga). Norway: J.A. Kvamme (Sleep Laboratory, ENT Department, Førde Central Hospital, Førde). Poland: P. Sliwinski and R. Plywaczewski (Institute of Tuberculosis and Lung Diseases, Dept of Diagnosis and Treatment of Respiratory Failure, Warsaw); P. Bielicki and J. Zielinski (Dept of Internal Medicine, Pneumonology and Allergology, Warsaw Medical University, Warsaw). Portugal: R. Staats (Dept of Respiratory Medicine, Hospital de Santa Maria, Lisbon); M. Drummond and M. van Zeller (Pulmonology Dept, Hospital São João, Medicine Faculty of Porto University, Porto). Slovakia: P. Joppa and R. Tkacova (Dept of Respiratory Medicine and Tuberculosis, Faculty of Medicine, P.J. Safarik University and L. Pasteur University Hospital, Kosice). Spain: J.M. Montserrat (Hospital Clinic i Provincial de Barcelona, Barcelona, IDIBAPS Barcelona and CIBERes, Madrid); J.F. Masa (Hospital San Pedro de Alcàntara, Cáceres); F. Barbé (Servei Pneumologia Hospital Arnau de Vilanova and Hospital Santa Maria, Lleida, and CIBERes, Madrid). Sweden: J. Hedner and L. Grote (Dept of Sleep Medicine, Sahlgrenska University Hospital, Gothenburg). UK: B. Kent (Guy's and St Thomas’ NHS Foundation Trust, Guy's Hospital, London); R.L. Riha (Dept of Sleep Medicine, Royal Infirmary Edinburgh). Turkey: O.K. Basoglu and M.S. Tasbakan (Dept of Chest Diseases, Ege University, Izmir). In addition, the following were centres in the start-up process: ENT Dept at Mainz University, Germany; Pulmonary Dept, University Hospital, Istanbul, Turkey.
Conflict of interest: M.R. Bonsignore has nothing to disclose.
Conflict of interest: J. Hedner reports grants from ResMed, Respironics and Bayer, for conduct of the ESASA database, and an issued patent related to sleep apnoea treatment.
- Received August 31, 2018.
- Accepted September 16, 2018.
- Copyright ©ERS 2018